Skip to Main Content

Paper Details

A randomized, placebo-controlled, double-blind study of sapropterin to treat ADHD symptoms and executive function impairment in children and adults with sapropterin-responsive phenylketonuria.
Mol Genet Metab
36
2015
Author NameAffiliation
Annette FeigenbaumThe Hospital for Sick Children and University of Toronto
  • 1 - 1

Datasets

Release 1.2